Related Experiment Videos
Cyclosporin A as a model antigen: immunochemical and structural studies
1UMR 7100 - CNRS/ULP 'Biotechnologie des Interactions Moléculaires', Ecole Supérieure de Biotechnologie de Strasbourg, Pôle API, Bld Sébastien Brandt, 67400 Illkirch, France. daniele.altschuh@esbs.u-strasbg.fr
Journal of Molecular Recognition : JMR
|November 26, 2002
Summary
Cyclosporin A, an immunosuppressant drug, was studied using antibody interactions to understand its structure and function. Research explored its conformations, binding mechanisms, and how structural changes affect its properties.
Area of Science:
- Immunology
- Structural Biology
- Pharmacology
Background:
- Cyclosporin A (CsA) is a cyclic undecapeptide immunosuppressant drug.
- It serves as a model antigen due to available structural data and analogs.
- Monoclonal antibody R45-45-11 provides a tool for studying CsA interactions.
Purpose of the Study:
- To review immunochemical and crystallographic studies on the interaction between antibody Fab and Cyclosporin A.
- To discuss the biologically active conformations of CsA.
- To elucidate the CsA-antibody recognition mechanism and structure-activity relationships.
Main Methods:
- Immunochemical studies
- X-ray crystallography
- Analysis of Cyclosporin A analogs
Main Results:
- Different conformations of CsA were identified, raising questions about the biologically active form.
- The recognition mechanism between the antibody Fab and CsA was detailed.
- Structure-binding property relationships for CsA analogs were established.
Conclusions:
- Understanding CsA conformations is crucial for its biological activity.
- The Fab-CsA interaction mechanism provides insights into drug recognition.
- Structure-activity relationship studies inform the development of CsA analogs.